These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy. Lai TY; Chan WM; Lam DS; Lim E Br J Ophthalmol; 2005 Jun; 89(6):774-5. PubMed ID: 15923521 [No Abstract] [Full Text] [Related]
8. [Ocular toxicity by the use of ethambutol]. Hernández Prats C; Escrivá Moscardó S; Martínez Pastor F; Pampliega Pérez A Farm Hosp; 2006; 30(4):262-4. PubMed ID: 17022723 [No Abstract] [Full Text] [Related]
9. [Optic nerve damage caused by administration of ethambutol]. Filipović T; Bujanić-Cuculić S; Bosković I Lijec Vjesn; 1997 Nov; 119(10):273-4. PubMed ID: 9531761 [TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy. Zoumalan CI; Sadun AA Br J Ophthalmol; 2007 Jun; 91(6):839-40. PubMed ID: 17510481 [No Abstract] [Full Text] [Related]
11. Ethambutol optic neuropathy associated with enhancement at the optic chiasm. Lu PG; Kung NH; Van Stavern GP Can J Ophthalmol; 2017 Oct; 52(5):e178-e181. PubMed ID: 28985827 [No Abstract] [Full Text] [Related]
12. Ocular ethambutol toxicity. Melamud A; Kosmorsky GS; Lee MS Mayo Clin Proc; 2003 Nov; 78(11):1409-11. PubMed ID: 14601701 [TBL] [Abstract][Full Text] [Related]
13. Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation. De Marinis M J Neurol; 2001 Sep; 248(9):818-9. PubMed ID: 11596792 [No Abstract] [Full Text] [Related]
14. Disentangling renal function in the context of irreversible ethambutol optic neuropathy. Chatziralli IP; Papazisis L; Keryttopoulos P; Papadopoulou D; Sergentanis TN Int Ophthalmol; 2010 Dec; 30(6):743-4. PubMed ID: 20111890 [No Abstract] [Full Text] [Related]
15. [Bilateral optic neuropathy induced by antituberculous treatment in a patient with renal failure]. Handor H; Ibrahimy W Pan Afr Med J; 2013; 16():42. PubMed ID: 24648855 [No Abstract] [Full Text] [Related]
16. Bitemporal visual field defects in ethambutol-induced optic neuropathy. Kho RC; Al-Obailan M; Arnold AC J Neuroophthalmol; 2011 Jun; 31(2):121-6. PubMed ID: 21597402 [TBL] [Abstract][Full Text] [Related]
17. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy. Chai SJ; Foroozan R Br J Ophthalmol; 2007 Jul; 91(7):895-7. PubMed ID: 17215265 [TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Zoumalan CI; Agarwal M; Sadun AA Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):410-6. PubMed ID: 15565293 [TBL] [Abstract][Full Text] [Related]
19. Ethambutol and optic neuropathy. Chuenkongkaew W; Samsen P; Thanasombatsakul N J Med Assoc Thai; 2003 Jul; 86(7):622-5. PubMed ID: 12948256 [TBL] [Abstract][Full Text] [Related]
20. Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year. Sadun AA; Wang MY J Neuroophthalmol; 2008 Dec; 28(4):265-8. PubMed ID: 19145122 [No Abstract] [Full Text] [Related] [Next] [New Search]